Teleflex Inc. stock edges higher as FY 2026 guidance and dividend underpin valuation
Published on 09/16/2026 at 21:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Teleflex Inc. stock (ISIN US8793691069) closed at USD 129.02 on the New York Stock Exchange on September 15, 2026, giving investors a fresh reference point after a volatile summer for medical device names. As of that date the shares traded roughly in the middle of their 52-week range, with fundamentals shaped by strong second-quarter figures and updated full-year guidance.
Q2 2026 results and guidance drive the story
According to MarketBeat, Teleflex reported earnings per share of USD 1.76 for the second quarter of 2026, comfortably above the consensus estimate of USD 1.28, a positive surprise of USD 0.48 per share.
In the same overview, Teleflex is reported to have generated revenue of USD 570.33 million in Q2 2026, representing an increase of 28.9 percent year over year and underlining robust growth in its portfolio of disposable medical devices and vascular access products compared with the prior-year quarter.MarketBeat
Looking ahead, Teleflex has set full-year 2026 earnings guidance at USD 6.90 to USD 7.20 per share, creating a tighter range for investors to calibrate expectations.MarketBeat For investors, the key question now is how much of the recent upside surprise and the guidance band is already reflected in the current share price.
Dividend, valuation and analyst views
Teleflex complements its earnings profile with a regular cash return to shareholders. As reported by MarketBeat, the company recently declared a quarterly dividend of USD 0.34 per share, which corresponds to an annualized yield of about 1.1 percent on the current share price and offers income-oriented investors a modest but steady payout.
On the valuation side, Teleflex’s average analyst price target stands at USD 152.90, implying upside potential of nearly 18.5 percent relative to the USD 129.02 closing level on September 15, 2026 if that target were reached.MarketBeat The same data set shows one analyst rating the stock Strong Buy, four at Buy, six at Hold and one at Sell, resulting in an overall Hold recommendation and signaling a balanced view between growth prospects and valuation risk.
Institutional investors remain heavily involved: California State Teachers Retirement System, for example, reduced its Teleflex stake by 1.2 percent in the second quarter by selling 607 shares, leaving 50,865 shares valued at around USD 6.45 million.MarketBeat According to the same source, institutional investors collectively own more than 95 percent of the company, a factor that tends to stabilize liquidity but may also amplify moves when large holders adjust their positions.
Stock level within 52-week range
Per recent trading data cited by MarketBeat, Teleflex stock recently changed hands at USD 128.92 during trading hours, with approximately 390,902 shares traded compared with an average volume of 769,650 shares. The company’s shares have traded between a 52-week low of USD 100.18 and a 52-week high of USD 145.00, placing the latest closing price of USD 129.02 roughly 28.9 percent above the low and about 11.0 percent below the high.
Within that range, the combination of double-digit revenue growth, guidance in the high single digits of EPS and a small but consistent dividend suggests a profile of a mature medtech company balancing expansion investments with cash returns. For investors assessing Teleflex Inc. stock as of September 16, 2026, the interplay of guidance, trading range and institutional positioning is central to understanding both the upside potential and the embedded risks.
Teleflex Inc. stock snapshot
- Company: Teleflex Inc.
- ISIN: US8793691069
- Ticker: TFX
- Trading venue: NYSE
- Price (as of September 15, 2026): 129.02 USD
- Market capitalization: 6.45 billion USD (as of September 15, 2026)
- Sector / Industry: Health Care / Medical Devices
- Index membership: S&P 500
